遼寧
圖片來源：Vaxart公司官網(wǎng)
參考資料
Flitter BA, Greco SN, Lester CA, et al. An oral norovirus vaccine tablet was safe and elicited mucosal immunity in older adults in a phase 1b clinical trial. Science Translational Medicine. 2025;17(788):eads0556. doi:10.1126/scitranslmed.ads0556
Kim L, Liebowitz D, Lin K, et al. Safety and immunogenicity of an oral tablet norovirus vaccine, a phase I randomized, placebo-controlled trial. JCI Insight. 2018;3(13):e121077, 121077. doi:10.1172/jci.insight.121077
Positive topline data from Phase II trial of Vaxart’s norovirus vaccine pill. Accessed May 1, 2025. https://www.clinicaltrialsarena.com/news/positive-topline-vaxart-norovirus-vaccine-pill/
This Week in Virology (TWiV) Episode 1209, https://www.microbe.tv/twiv/twiv-1209/
Vaxart. Vaxart, Inc. –Vaxart Completes Enrollment in Phase 1 Trial for its Norovirus Oral Pill Vaccine Candidate. Vaxart. April 30, 2025. Accessed May 1, 2025. https://investors.vaxart.com/news-releases/news-release-details/vaxart-completes-enrollment-phase-1-trial-its-norovirus-oral
歡迎來到醫(yī)食參考新媒體矩陣
2023年疫苗接種攻略
陽過了，該怎么打疫苗？最全接種指導(dǎo)手冊(cè)來了
撰寫| CNVAC
校稿| Gddra編審| Hide / Blue sea
編輯 設(shè)計(jì)| Alice
特別聲明：以上內(nèi)容(如有圖片或視頻亦包括在內(nèi))為自媒體平臺(tái)“網(wǎng)易號(hào)”用戶上傳并發(fā)布，本平臺(tái)僅提供信息存儲(chǔ)服務(wù)。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
